Adding an artificial tumor-specific receptor to immune system cells called T-lymphocytes that target a particular virus extended and improved the cells’ ability to fight a form of childhood cancer called neuroblastoma, said researchers.
Adding an artificial tumor-specific receptor to immune system cells called T-lymphocytes that target a particular virus extended and improved the cells’ ability to fight a form of childhood cancer called neuroblastoma, said researchers.